Covetrus Stock Price, News & Analysis

Covetrus Inc. is a global animal-health technology and services company that provides products, services, and technology for veterinary practices. The company describes its operating model as a single platform that connects veterinary practice partners with solutions and insights used in animal care and practice operations. Covetrus is headquartered in Portland, Maine, and its historical public-company ticker was CVET on Nasdaq.

The company’s business is centered on the veterinary community. Its offerings include animal-health products, practice services, prescription management capabilities, proprietary brands, and technology tools that support veterinarians, their practices, and patients. Covetrus has described its mission in terms of improving health and financial outcomes for veterinary practice partners by combining distribution, services, and technology into an integrated platform.

As a public company, Covetrus reported activity across geographic operating areas that included North America, Europe, and APAC & Emerging Markets. Company updates referenced demand for prescription management, adoption of its technology stack, growth of proprietary brands, and management of corporate costs as recurring operating themes. Its customer base and operating focus were global, with veterinary practices as the core end market.

The CVET ticker also represents a completed corporate-status history. Former holders of Covetrus common stock had their shares exchanged for cash on October 13, 2022, and later stockholder litigation materials referenced those former holders and the exchange of Covetrus securities. Subsequent company announcements continued to describe Covetrus as an animal-health technology and services company, while the CVET symbol remains a historical reference to the company’s former Nasdaq-listed public equity.